These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25404522)

  • 1. HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation Levels.
    Eller MA; Opollo MS; Liu M; Redd AD; Eller LA; Kityo C; Kayiwa J; Laeyendecker O; Wawer MJ; Milazzo M; Kiwanuka N; Gray RH; Serwadda D; Sewankambo NK; Quinn TC; Michael NL; Wabwire-Mangen F; Sandberg JK; Robb ML
    J Infect Dis; 2015 May; 211(10):1574-84. PubMed ID: 25404522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection.
    Kiwanuka N; Laeyendecker O; Robb M; Kigozi G; Arroyo M; McCutchan F; Eller LA; Eller M; Makumbi F; Birx D; Wabwire-Mangen F; Serwadda D; Sewankambo NK; Quinn TC; Wawer M; Gray R
    J Infect Dis; 2008 Mar; 197(5):707-13. PubMed ID: 18266607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short Communication: The Interaction of HIV Set Point Viral Load and Subtype on Disease Progression.
    McPhee E; Grabowski MK; Gray RH; Ndyanabo A; Ssekasanvu J; Kigozi G; Makumbi F; Serwadda D; Quinn TC; Laeyendecker O
    AIDS Res Hum Retroviruses; 2019 Jan; 35(1):49-51. PubMed ID: 30520309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of HIV-1 subtypes on disease progression in rural Uganda: a prospective clinical cohort study.
    Ssemwanga D; Nsubuga RN; Mayanja BN; Lyagoba F; Magambo B; Yirrell D; Van der Paal L; Grosskurth H; Kaleebu P
    PLoS One; 2013; 8(8):e71768. PubMed ID: 23951241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short communication: HIV type 1 subtype BF leads to faster CD4+ T cell loss compared to subtype B.
    Tarosso LF; Sanabani SS; Ribeiro SP; Sauer MM; Tomiyama HI; Sucupira MC; Diaz RS; Sabino EC; Kalil J; Kallas EG
    AIDS Res Hum Retroviruses; 2014 Feb; 30(2):190-4. PubMed ID: 23906381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts.
    Touloumi G; Pantazis N; Pillay D; Paraskevis D; Chaix ML; Bucher HC; Kücherer C; Zangerle R; Kran AM; Porter K;
    Clin Infect Dis; 2013 Mar; 56(6):888-97. PubMed ID: 23223594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort.
    Kaleebu P; Ross A; Morgan D; Yirrell D; Oram J; Rutebemberwa A; Lyagoba F; Hamilton L; Biryahwaho B; Whitworth J
    AIDS; 2001 Feb; 15(3):293-9. PubMed ID: 11273208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads.
    Baeten JM; Chohan B; Lavreys L; Chohan V; McClelland RS; Certain L; Mandaliya K; Jaoko W; Overbaugh J
    J Infect Dis; 2007 Apr; 195(8):1177-80. PubMed ID: 17357054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 disease progression and AIDS-defining disorders in rural Uganda.
    Morgan D; Maude GH; Malamba SS; Okongo MJ; Wagner HU; Mulder DW; Whitworth JA
    Lancet; 1997 Jul; 350(9073):245-50. PubMed ID: 9242801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype.
    Vasan A; Renjifo B; Hertzmark E; Chaplin B; Msamanga G; Essex M; Fawzi W; Hunter D
    Clin Infect Dis; 2006 Mar; 42(6):843-52. PubMed ID: 16477563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa.
    Gray CM; Williamson C; Bredell H; Puren A; Xia X; Filter R; Zijenah L; Cao H; Morris L; Vardas E; Colvin M; Gray G; McIntyre J; Musonda R; Allen S; Katzenstein D; Mbizo M; Kumwenda N; Taha T; Karim SA; Flores J; Sheppard HW
    AIDS Res Hum Retroviruses; 2005 Apr; 21(4):285-91. PubMed ID: 15943570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid disease progression in human immunodeficiency virus type 1-infected seroconverters in India.
    Mehendale SM; Bollinger RC; Kulkarni SS; Stallings RY; Brookmeyer RS; Kulkarni SV; Divekar AD; Gangakhedkar RR; Joshi SN; Risbud AR; Thakar MA; Mahajan BA; Kale VA; Ghate MV; Gadkari DA; Quinn TC; Paranjape RS
    AIDS Res Hum Retroviruses; 2002 Nov; 18(16):1175-9. PubMed ID: 12487823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 subtype dynamics over 10 years in a rural Ugandan cohort.
    Yirrell DL; Kaleebu P; Morgan D; Hutchinson S; Whitworth JA
    Int J STD AIDS; 2004 Feb; 15(2):103-6. PubMed ID: 15006072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa.
    Amornkul PN; Karita E; Kamali A; Rida WN; Sanders EJ; Lakhi S; Price MA; Kilembe W; Cormier E; Anzala O; Latka MH; Bekker LG; Allen SA; Gilmour J; Fast PE;
    AIDS; 2013 Nov; 27(17):2775-86. PubMed ID: 24113395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection.
    Eggena MP; Barugahare B; Okello M; Mutyala S; Jones N; Ma Y; Kityo C; Mugyenyi P; Cao H
    J Infect Dis; 2005 Mar; 191(5):694-701. PubMed ID: 15688282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.
    Mermin J; Lule J; Ekwaru JP; Malamba S; Downing R; Ransom R; Kaharuza F; Culver D; Kizito F; Bunnell R; Kigozi A; Nakanjako D; Wafula W; Quick R
    Lancet; 2004 Oct 16-22; 364(9443):1428-34. PubMed ID: 15488218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment failure and drug resistance is more frequent in HIV-1 subtype D versus subtype A-infected Ugandans over a 10-year study period.
    Kyeyune F; Nankya I; Metha S; Akao J; Ndashimye E; Tebit DM; Rodriguez B; Kityo C; Salata RA; Mugyenyi P; Arts E;
    AIDS; 2013 Jul; 27(12):1899-909. PubMed ID: 23727942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus-specific responses in adult Ugandans: patterns of cross-clade recognition.
    Barugahare B; Baker C; K'Aluoch O; Donovan R; Elrefaei M; Eggena M; Jones N; Mutalya S; Kityo C; Mugyenyi P; Cao H
    J Virol; 2005 Apr; 79(7):4132-9. PubMed ID: 15767414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of HIV-infected treatment-naive individuals with documented dates of seroconversion in Rakai, Uganda.
    Lutalo T; Gray RH; Wawer M; Sewankambo N; Serwadda D; Laeyendecker O; Kiwanuka N; Nalugoda F; Kigozi G; Ndyanabo A; Bwanika JB; Reynolds SJ; Quinn T; Opendi P
    AIDS; 2007 Nov; 21 Suppl 6():S15-9. PubMed ID: 18032934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell depletion in HIV-1 subtype A infected Ugandan adults: relationship to CD4 T cell count, viral load and humoral immune responses.
    Oballah P; Flach B; Eller LA; Eller MA; Ouma B; de Souza M; Kibuuka HN; Wabwire-Mangen F; Brown BK; Michael NL; Robb ML; Montefiori D; Polonis VR
    PLoS One; 2011; 6(8):e22653. PubMed ID: 21886768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.